Technical Analysis for IGX - IntelGenx Technologies Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Crossed Above 20 DMA | Bullish | 2.04% | |
Bollinger Band Squeeze | Range Contraction | 2.04% | |
Narrow Range Bar | Range Contraction | 2.04% | |
BB Squeeze Started | Range Contraction | 2.04% | |
Gapped Up | Strength | 2.04% | |
Narrow Range Bar | Range Contraction | 11.11% |
Get a Trading Assistant
- Earnings date: 2024-05-09
IntelGenx Technologies Corp. Description
IntelGenx Technologies Corp., a drug delivery company, focuses on the development of novel oral thin film products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2008 for migraine; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease. It is also developing INT0037/2013, INT0039/2013, and INT0040/2014. The company has co-development and commercialization agreements with RedHill Biopharma Ltd., Par Pharmaceutical Companies, Inc., and Endo Ventures Ltd.; licensing, development, and supply agreement with Tilray, Inc., Gensco Pharma, and Insud Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharma Pharmaceutical Delivery Montreal Drug Pain Disease Cancer Drugs Grain Alzheimer's Disease Drug Delivery Tilray Pharmaceutical Companies Schizophrenia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.35 |
52 Week Low | 0.135 |
Average Volume | 16,899 |
200-Day Moving Average | 0.209 |
50-Day Moving Average | 0.221 |
20-Day Moving Average | 0.238 |
10-Day Moving Average | 0.237 |
Average True Range | 0.014 |
RSI (14) | 56.33 |
ADX | 11.68 |
+DI | 39.183 |
-DI | 31.587 |
Chandelier Exit (Long, 3 ATRs) | 0.219 |
Chandelier Exit (Short, 3 ATRs) | 0.251 |
Upper Bollinger Bands | 0.260 |
Lower Bollinger Band | 0.217 |
Percent B (%b) | 0.77 |
BandWidth | 18.044 |
MACD Line | 0.005 |
MACD Signal Line | 0.005 |
MACD Histogram | -0.0005 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.250 | ||||
Resistance 3 (R3) | 0.250 | 0.250 | 0.250 | ||
Resistance 2 (R2) | 0.250 | 0.250 | 0.250 | 0.250 | |
Resistance 1 (R1) | 0.250 | 0.250 | 0.250 | 0.250 | 0.250 |
Pivot Point | 0.250 | 0.250 | 0.250 | 0.250 | 0.250 |
Support 1 (S1) | 0.250 | 0.250 | 0.250 | 0.250 | 0.250 |
Support 2 (S2) | 0.250 | 0.250 | 0.250 | 0.250 | |
Support 3 (S3) | 0.250 | 0.250 | 0.250 | ||
Support 4 (S4) | 0.250 |